X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (26) 26
humans (24) 24
female (21) 21
pathology (15) 15
breast cancer (14) 14
breast neoplasms - genetics (13) 13
comparative genomic hybridization (13) 13
oncology (12) 12
breast neoplasms - pathology (11) 11
breast neoplasms - metabolism (8) 8
amplification (7) 7
gene amplification (7) 7
microarray (7) 7
cancer (6) 6
cell line, tumor (6) 6
chromosome aberrations (6) 6
genes (6) 6
immunohistochemistry (6) 6
in situ hybridization (6) 6
tumors (6) 6
analysis (5) 5
genetic aspects (5) 5
mutation (5) 5
oligonucleotide array sequence analysis (5) 5
phenotype (5) 5
adult (4) 4
aged (4) 4
array-cgh (4) 4
basal-like (4) 4
biomarkers, tumor - metabolism (4) 4
carcinoma, ductal, breast - genetics (4) 4
carcinoma, ductal, breast - pathology (4) 4
cluster analysis (4) 4
gene expression regulation, neoplastic (4) 4
genomics (4) 4
in situ hybridization, fluorescence (4) 4
in-situ hybridization (4) 4
medicine, research & experimental (4) 4
middle aged (4) 4
nucleic acid hybridization - methods (4) 4
progression (4) 4
research (4) 4
treatment outcome (4) 4
abridged index medicus (3) 3
carcinoma - metabolism (3) 3
carcinoma, ductal, breast - metabolism (3) 3
carcinomas (3) 3
chromogenic compounds (3) 3
chromogenic in situ hybridization (3) 3
chromosomes (3) 3
cyclin d1 (3) 3
differentiation (3) 3
dna (3) 3
growth-factor receptor (3) 3
hybridization (3) 3
microarrays (3) 3
mutations (3) 3
oligonucleotide array sequence analysis - methods (3) 3
ovarian neoplasms - genetics (3) 3
prognosis (3) 3
therapeutic target (3) 3
adenocarcinoma (2) 2
adenocarcinoma, clear cell - genetics (2) 2
adenoma, pleomorphic - genetics (2) 2
adenoma, pleomorphic - pathology (2) 2
biomarkers, tumor - analysis (2) 2
breast (2) 2
breast carcinoma (2) 2
breast neoplasms - therapy (2) 2
breast-cancer (2) 2
cancer cell-lines (2) 2
cancer subtypes (2) 2
carcinoma (2) 2
carcinoma - genetics (2) 2
carcinoma - pathology (2) 2
ccnd1 amplification (2) 2
cell biology (2) 2
cell-lines (2) 2
chemotherapy (2) 2
chemotherapy, adjuvant (2) 2
chromosomes, artificial, bacterial (2) 2
cish (2) 2
development and progression (2) 2
disease-free survival (2) 2
displacement amplification (2) 2
epidermal growth factor (2) 2
epidermal growth factor receptors (2) 2
erbb-2 protein (2) 2
expression (2) 2
fluorescent in situ hybridization (2) 2
gene expression (2) 2
gene expression profiling (2) 2
genetic research (2) 2
genetics (2) 2
genetics & heredity (2) 2
identification (2) 2
immunohistochemistry - methods (2) 2
immunophenotyping (2) 2
in situ hybridization - methods (2) 2
male (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Urology, ISSN 0302-2838, 10/2019, Volume 76, Issue 4, pp. 469 - 478
Prostate-specific membrane antigen (PSMA; folate hydrolase) prostate cancer (PC) expression has theranostic utility. To elucidate PC PSMA expression and... 
Castration-resistant prostate cancer | Treatment resistance | Prostate-specific membrane antigen | Tumour heterogeneity | Defective DNA repair | BRCA2 | Prostate cancer | Theranostics | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2019, Volume 37, Issue 24, pp. JCO.19.01104 - 2184
Journal Article
Journal of Pathology, ISSN 0022-3417, 04/2010, Volume 220, Issue 5, pp. 562 - 573
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2009, Volume 15, Issue 7, pp. 2269 - 2280
Journal Article
Journal Article
Journal Article
Human Pathology, ISSN 0046-8177, 08/2007, Volume 38, Issue 8, p. 1105
  Fluorescent (FISH) and chromogenic (CISH) in situ hybridization have recently become part of the diagnostic armamentarium of breast pathologists. HER2 gene... 
Medical research | Genes | Genetics | Breast cancer | Mutation
Journal Article
Journal of Pathology, ISSN 0022-3417, 07/2009, Volume 218, Issue 3, pp. 301 - 315
Micropapillary carcinomas (MPCs) can present as a rare histological special type of breast cancer; however, this histological type is more frequently found... 
Chromogenic in situ hybridization | Breast cancer | Comparative genomic hybridization | Microarray | Histological type | chromogenic in situ hybridization | IN-SITU HYBRIDIZATION | breast cancer | PATHOLOGY | comparative genomic hybridization | BASAL-LIKE | HISTOLOGICAL GRADE | microarray | ARRAY CGH DATA | AMPLIFICATION | ONCOLOGY | THERAPEUTIC TARGET | TERM-FOLLOW-UP | histological type | PROGRESSION | CANCER CELL-LINES | Carcinoma, Ductal, Breast - genetics | Neoplasms, Complex and Mixed - genetics | Carcinoma, Papillary - genetics | Oligonucleotide Array Sequence Analysis | Humans | Immunophenotyping | Neoplasm Proteins - metabolism | Carcinoma, Papillary - pathology | Carcinoma, Papillary - metabolism | Breast Neoplasms - metabolism | Breast Neoplasms - genetics | Comparative Genomic Hybridization | Breast Neoplasms - pathology | Chromosome Aberrations | Neoplasms, Complex and Mixed - pathology | Biomarkers, Tumor - metabolism | Carcinoma, Ductal, Breast - pathology | Female | Carcinoma, Ductal, Breast - metabolism | Neoplasms, Complex and Mixed - metabolism | Index Medicus | Cytokeratin | Epidermal growth factor receptors | Invasiveness | Antibodies | Estrogen receptors | Myc protein | ErbB-2 protein | Progesterone receptors | Breast carcinoma | caveolin-1 | Gene amplification | E-Cadherin | genomics | cyclin D1 | Differentiation | Fibroblast growth factor receptor 1
Journal Article